Established in 2021, based in Shanghai, PR China, ProOnco Therapeutics is a contract research organization(CRO). ProOnco Therapeutics provides service majorly in preclinical stage, covering target discovery, target identification, assay development, compound screening, DMPK&ADME, and animal disease models.
We are committed to delivering high-quality and reproducible data, in vivo, in vitro and ex vivo studies. We are committed to building up strong relationship with clients and we value longer term benefits for both sides. We have implemented stronger IP protection all-around for world wise clients.
